CHRO 2024
Sponsors
Gold Sponsor
Tri-Med
Based in Perth, Western Australia, Tri-Med was founded in 1996 by Professor Barry Marshall to develop a reliable diagnostic test to detect Helicobacter pylori (H.pylori).
Tri-Med’s PYtest® is a urea breath test; a simple, quantitative and non-invasive method for the diagnosis of current H. pylori infection.
Over the last three decades, PYtest has evolved into one of the world’s most trusted diagnostic tests for the detection of H. pylori.
Today, Tri-Med has expanded both its product base and international footprint, marketing PYtest, CLOtest, scintillation and collection fluids and associated therapeutics throughout Australia and to a worldwide market including over 30 export destinations.
Tri-Med has representative offices in Australia, the United States and India.
For further information, log into www.trimed.com.au
Gala Dinner Partner
University of Western Australia
Starting where Western Australian kaartdijin (knowledge) began, The University of Western Australia sits on sacred soil alongside the Derbal Yerrigan (Swan River) on Whadjuk Noongar Booja.
It has been a place to gather and learn for tens of thousands of years, sharing life lessons through stories that have been passed down from generation to generation of the world’s oldest continuous culture.
Established as the State’s first university in 1911 and founded with a mission to ‘advance the prosperity and welfare of our communities’, the University opened in 1913 to just 184 students. Today, more than 25,000 students are enrolled from 100 countries.
Since our beginnings, UWA has blazed the trail in producing remarkable and life-changing contributions across learning, teaching and research. But our University is more than simply a centre for education and research.
For more than 100 years, we have contributed to the intellectual, cultural and economic development of Western Australia, the nation and our world. We have forged and embraced connections with community, partners and industry to ensure our impact is far reaching, both now and into the future.
We’re continuing to make our mark on the world and our students are vital in this journey. UWA students contribute to society in ways that tackle our world’s most pressing challenges. From health and social inequalities to the environment and climate change, our passionate community of students, academics and researchers are partnering with industry to help solve these Grand Challenges.
Our motto ‘Seek Wisdom’ is as relevant today and into the future as it was when it was adopted by the UWA Senate in 1912. We remain committed to this, as we continue to encourage our students and staff to push beyond the bounds of what is known and what is possible.
International Speaker Partner
2024 Rehabilitation Summit
The 2024 Rehabilitation Summit at the China International Import Expo will bring together global experts, to discuss cutting-edge rehabilitation technologies and opportunities for industry development. With keynote speeches, expert panels, and roundtable discussions, the summit aims to foster innovation, international collaboration, and advancements in global healthcare and rehabilitation.
Destination Sponsor
Exhibitors
Biotome
Specializing in peptide-based diagnostics, Biotome offers services in epitope mapping and diagnostic development, antibody characterization and profiling, and IP consulting. Biotome is a commercial partner on many research grants, collaborating with researchers and institutions around the world. We are developing Helitope – a next-generation test for H. pylori Cag-A antibodies and monoclonals for Cag-A protein detection.
Government of Western Australia – Department of Health
The Department of Health drives health and medical research, innovation and translation across WA through the Office of Medical Research and Innovation (OMRI). It achieves this by:
• providing support to the Future Health Research and Innovation (FHRI) Fund which has delivered over $100 million in funding.
• supporting the implementation of the WA Health and Medical Research Strategy
• providing advice across the WA health system for the management of Intellectual Property
• managing the Research Governance Service (RGS) to ensure research applications align with national and state policies.
Genoimage
JIYING TECHNOLOGY CO., LIMITED, founded in 2019 in Hong Kong Science Park, focuses on advanced life sciences technologies, including clinical medicine, AI, pharmacy, and genetics. The company develops innovative medical AI products to enhance diagnosis and treatment. Founded by experts in medical field, 100% of its R&D personnel hold a Master Degree or higher, with 85% having a Doctorate. We have filed 4 patents and won multiple awards in Hong Kong and China. Our products, such as gastrointestinal endoscopy and digestive tract early cancer AI identification system (Genoimage®), have been launched to the market. Our coverage includes Hong Kong, China, Southeast Asia, and Africa.
Hongmed-Infagen
Shenzhen Hongmed-Infagen Co., LTD. was founded in 2015 by scientists from China and Australia. It is a high-tech enterprise that has its own R&D, manufacture and sales in clinical diagnostics and life science products. The company has gathered a team of talented foreign professionals, including one Nobel Laureate in Physiology or Medicine, and two “Shenzhen Overseas High-level Talents”. The company is currently focusing on the diagnosis of gastrointestinal diseases associated with Helicobacter pylori, facilitate personalized treatment on multi-drug resistant Helicobacter pylori, promotes intestinal cancer screening and the prevention of gastric cancer.
The company comprises about 3,000 square meters in Shenzhen, which includes offices, 500 square meters of R&D laboratory, and a 1000 square meters GMP manufacturing space. Under the guidance of Nobel Prize winner Professor Barry Marshall, the company’s aim is to stand in the very forefront of precision diagnosis and treatment of digestive tumors and strive to become a world-class biomedical high-end manufacturing company.
Tri-Med
Based in Perth, Western Australia, Tri-Med was founded in 1996 by Professor Barry Marshall to develop a reliable diagnostic test to detect Helicobacter pylori (H.pylori).
Tri-Med’s PYtest® is a urea breath test; a simple, quantitative and non-invasive method for the diagnosis of current H. pylori infection.
Over the last three decades, PYtest has evolved into one of the world’s most trusted diagnostic tests for the detection of H. pylori.
Today, Tri-Med has expanded both its product base and international footprint, marketing PYtest, CLOtest, scintillation and collection fluids and associated therapeutics throughout Australia and to a worldwide market including over 30 export destinations.
Tri-Med has representative offices in Australia, the United States and India.
For further information, log into www.trimed.com.au
Wonderlab
WonderLab was established in Shenzhen, China in 2019. It specializes in the research of evidence-based probiotics and nutritional supplements to provide consumers high-quality nutritional products and health services, so that more people can get a better and healthier life. Its probiotic and other series of products are deeply loved by consumers and have served more than 5 million users.